Time-dependent sensitization (TDS) refers to the ability of drugs and nondrug stressors to trigger biological and behavioral effects which continue to grow, ie, strengthen, with the passage of time even long after the initiating stimulus has left the body or is no longer present in the environment. The induction of TDS is independent of the pharmacology of a given agent, requires only a single exposure and yet progresses for extraordinary periods. It has been demonstrated for so many diverse drugs and non-pharmacological stressful stimuli and in so many systems that it clearly reflects a general principle of biological functioning which is likely to be common to all systems. TDS appears to be a phylogenetically-old memory process which has an important role to play in the induction and novel treatment of numerous diseases.
MILLENNIUM ARTICLE Neurotransmitter transporters: fruitful targets for CNS drug recovery L Iversen
A number of different chemical messengers occur in the nervous system. Minute amounts of these chemicals are released from nerve terminals when a nerve impulse reaches the terminal and after their release they activate specific receptor molecules present on the surface of adjacent cells to activate or inhibit target cell activity. The actions of the released chemical neurotransmitter molecules are terminated by a series of uptake mechanisms which recapture the released chemical and recycle it into storage vesicles in the nerve terminal ready for re-use. These uptake systems involve a family of some 20 different proteins known as transporters. These form the target for important drugs used in psychiatry, the tricyclic antidepressants and more modern drugs such as fluoxetine act to inhibit norepinephrine and/or serotonin reuptake. Amphetamines, used in the treatment of attention deficit hyperactivity disorder, inhibit dopamine reuptake and storage and promote dopamine release in the brain.
IMMEDIATE COMMUNICATION
Apolipoprotein E is a genetic risk factor for fetal iodine deficiency disorder in China HY Wang, FC Zhang, JJ Gao, JB Fan, P Liu, ZJ Zheng, H Xi, Y Sun, XC Gao, TZ Huang, ZJ Ke, GR Guo, GY Feng, G Breen, D St Clair, L He Fetal iodine deficiency disorder also known as endemic cretinism is the commonest cause of preventable mental retardation worldwide. It is especially prevalent in the many mountain areas of China where its presence has been recorded from earliest times. Vulnerability to FIDD is partly familial. Not everyone at risk develops FIDD and aggregation is common in families. The Apolipoprotein E (APOE) gene encodes for a lipoprotein that possesses a thyroid hormone-binding domain, and APOE genotype may affect the efficiency with which thyroid hormone influences neuronal cell growth during the first and second trimesters of fetal development. The authors have compared ApoE genotypes in FIDD cases recruited from three separate iodine-deficient areas of north west China. In each area APOE ⑀ 4 genotypes were significantly enriched in FIDD probands and other affected relatives compared to family, iodine-deficient and normal controls. APOE ⑀ 4 allele therefore seems to be a genetic risk factor for FIDD. The phenomenon may affect population selection and contribute to the low frequency of the ⑀ 4 allele in Chinese compared to Caucasian populations.
ORIGINAL RESEARCH ARTICLES
A genetic screen for novel behavioral mutants in mice DM Sayah, AH Khan, TL Gasperoni, DJ Smith Despite substantial efforts, the genetic basis of human psychiatric illness remains largely unknown. Attempts to isolate predisposing genes have been challenged by polygenic inheritance patterns, disease heterogeneity, and important environmental influences. One approach to circumventing these complexities is to use Molecular Psychiatry chemical mutagenesis of genetically defined mouse strains to allow identification of single genes affecting behavior. To this end, the authors conducted a largescale screen to isolate dominant mutations influencing mouse behavior. Mice were mutagenized with the chemical ENU and then bred to examine their G1 offspring for deviant behavior. Over 400 mice were screened on a variety of behavioral assays, including tests of learning and memory, sensorimotor gating, fear and anxiety, nociception, and locomotor activity. Outliers included both animals with deficits in single behavioral domains and animals that appeared abnormal on a range of tests. The authors identified three confirmed mutants, two affecting sensorimotor gating and one affecting craniofacial development. Mutagenesis screens represent a powerful tool for understanding the relationship between genes, brain, and behavior and will likely provide important new insights into the genetic basis of human psychiatric and neurological disease.
Selective increase of dopamine D3 receptor gene expression as a common effect of chronic antidepressant treatments C-H Lammers, J Diaz, J-C Schwartz, P Sokoloff
In spite of the long-standing clinical use of antidepressant drugs, the mechanism underlying their therapeutic effect is incompletely understood, but seems to involve the mesolimbic dopaminergic system, a neuroanatomical key structure for reward and motivation. The authors show that chronic administration of antidepressants of several classes, including inhibitors of monoamines uptake or monoamine oxidase, and repeated electroconvulsive shock treatments (ECT) all increase dopamine D3 receptor expression in a major projection area of the mesolimbic dopaminergic system. The time-course of altered D3 receptor expression, in line with the delayed clinical efficiency of antidepressant treatments, and the fact that various antidepressant drugs and ECT treatments produced the same effects, suggest that increased expression of the D3 receptor in the shell of nucleus accumbens participates in the therapeutic action of antidepressant treatments, by enhancing responsiveness to the mesolimbic dopaminergic system. These results suggest the use of D3 receptor agonists as antidepressant drugs.
Identification of candidate genes for psychiatric disorders on 18p11 K Rojas, L Liang, EI Johnson, WH Berrettini, J Overhauser
There are multiple genes for psychiatric illness that map throughout the genome. One gene implicated in bipolar disorder and schizophrenia has been mapped to the short arm of chromosome 18. Statistical methods suggest that this gene maps near the gene for a G-protein, called G(olf). The authors have attempted to identify new genes that map near the G(olf) gene. A total of six partial cDNA clones were identified that detect unique mRNA transcripts on Northern blots containing various adult tissues. Additional cDNA clones that did not detect signals on Northern blots were also isolated. These cDNA clones will provide new resources for screening for a gene involved in psychiatric illness. Attention deficit hyperactivity disorder (ADHD), characterized by a persistent pattern of overactivity, inattention and impulsivity, is a common neuropsychiatric disorder with onset in early childhood. Several lines of evidence suggest that regulation of dopamine neurotransmission is a key factor in the aetiology of the disorder. In particular, there have been a number of positive associations and linkage reports with dopamine 4 receptor (DRD4) and dopamine transporter gene (DAT1). Here the authors have investigated DRD4 and dopamine 5 receptor (DRD5) polymorphisms in a sample of Turkish ADHD children. Using within-family tests of association and linkage, they found increased transmission of the DRD4 7-repeat allele (DRD4*7) and a trend in the DRD5 polymorphism. There was evidence of an interaction with methylphenidate (MPH) response in both genes and analysis of the sample excluding non-responders revealed more significant evidence for the association. Analysis on dimensional measures of ADHD symptom domains, using T-tests and logistic regression TDT analyses of DRD4*7 transmission showed an inverse relation. Although this finding is only speculative at this stage, it suggests that in this sample DRD4*7 is associated with a lower level of ADHD symptomatology. The gene for the synaptic vesicle docking fusion protein, synaptosomal-associated protein of 25 kDa (SNAP-25), has been suggested to be involved in the etiology of attention-deficit hyperactivity disorder (ADHD) based on the mouse mutant strain coloboma. This neutron-irradiation induced mouse strain is hemizygous for the deletion of the SNAP-25 gene and displays spontaneous hyperactivity that is responsive to dextroamphetamine. Because of these characteristics, this strain has been suggested to be a mouse model for ADHD. DNA polymorphisms were identified in the 3Ј untranslated region of the human SNAP-25 gene and used for linkage analysis of this gene and ADHD in a sample of 97 small nuclear families. The transmission of the alleles of each of these polymorphisms and the haplotypes of both polymorphisms was examined using the transmission disequilibrium test. Biased transmission of the haplotypes of the alleles of these two polymorphisms was observed, suggesting a potential role of this gene in ADHD. Tardive dyskinesia (TD) is a common side effect correlated with antipsychotic treatment of schizophrenia and is a condition that adversely affects patient compliance and quality of life. Prolonged antipsychotic exposure and total antipsychotic dose is often associated with TD in predisposed patients. The authors have previously shown that variation in the dopamine D3 receptor gene contributes to some of this predisposition to TD. Accumulating evidence suggests that inter-individual variation in antipsychotic metabolism may also contribute to an individual's propensity to develop TD. Considerable support exists proposing that the cytochrome P450 1A2 enzyme may also be involved in the metabolism of typical antipsychotics and risk to TD development. To elucidate the potential role of the CYP1A2 gene in TD susceptibility, the authors investigated a novel functionally relevant polymorphism in the CYP1A2 gene with a continuous measure genetic association strategy. Although replication in independent samples is necessary, these findings provide initial support for a contribution of the liver enzyme gene CYP1A2 to TD susceptibility.
Dopamine D4 receptor 48-bp repeat polymorphism: no association with response to antipsychotic treatment, but association with catatonic schizophrenia R Kaiser, M Kö nneker, M Henneken, M Dettling, B Mü ller-Oerlinghausen, I Roots, J Brockmö ller
The dopamine D 4 receptor (DRD4) may play a role in the pathogenesis of neuropsychiatric disease and in the action of dopaminergic drugs. The 48-bp repeat polymorphism (48-bp VNTR) was studied in 638 patients with acute schizophrenic psychoses, as well as with two reference groups. Catatonic patients (DSM-IV 295.2) more frequently carried the DRD4 D 4.2 and D 4.3 allele than did all other schizophrenic cases (PϽ0.001, OR: 2.7, CI: 1.5-4.9) and controls (PϽ0.004, OR: 2.3, CI: 1.3-4.2). The authors found no significant difference in the DRD4 allele or in genotype frequencies in their comparison of all schizophrenic patients and controls. The 48-bp VNTR was not a predictor for therapeutic outcome measured by the positive and negative symptoms scale. These data exclude a major role of DRD4 48-bp VNTR in response to therapy and as a susceptibility factor for schizophrenia, but catatonic schizophrenia may be associated with the D 4.2 and DR 4.3 alleles.
Molecular Psychiatry
Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression: a study of complexin mRNAs SL Eastwood, PJ Harrison Alterations in synaptic structure and function may underlie the abnormal activity and integration of brain regions seen in schizophrenia. Measuring the expression of synaptic proteins, such as complexin I and II, is one approach to this question. The authors previously showed that mRNAs encoding the complexins were decreased in the hippocampus in schizophrenia. In this study they replicate the finding and show similar, though more extensive, reductions in bipolar disorder, but no changes in major depression. The results support the view that synaptic abnormalities are a feature of schizophrenia, and suggest that they may also occur in bipolar disorder. Together with other recent data, the data illustrate that neuropathology is becoming another area in which the 'continuum versus dichotomy' controversy about the relationship between the functional psychoses is played out.
Mutation and association analysis of the 5Ј region of the dopamine D3 receptor gene in schizophrenia patients: identification of the Ala38Thr polymorphism and suggested association between DRD3 haplotypes and schizophrenia H Ishiguro, Y Okuyama, M Toru, T Arinami
This paper reported a search for mutations in the 5Ј region of the DRD3 gene and a haplotypic association. Three novel polymorphisms: −712G/C, −205A/G, and Ala38Thr were detected. The Ala38Thr polymorphism is located in the first transmembrane region and is conserved in the monkey, mouse, and rat. Case-control comparisons in Japanese schizophrenia patients and Japanese controls revealed a significant association between haplotypes of the −712G/C, −205A/G, and Ser9Gly polymorphisms and schizophrenia. These positive findings were replicated in additional Japanese schizophrenia patients and controls. The most allelic differences of the Ser9Gly polymorphism between patient and control groups arose from the chromosome carrying specific alleles of the other three polymorphisms. This study indicates unknown variant(s) in linkage disequilibrium with the DRD3 haplotypes associated with schizophrenia.
Allelic distribution of CTG18.1 in Caucasian populations: association studies in bipolar disorder, schizophrenia, and ataxia MG McInnis, T Swift-Scanlanl, AT Mahoney, J Vincent, G Verheyen, T Hung Lan, L Oruc, O Riess, C Van Broeckhoven, H Chen, JL Kennedy, DF MacKinnon, RL Margolis, SG Simpson, FJ McMahon, E Gershon, J Nurnberger Jr, T Reich, JR DePaulo, CA Ross Genes containing unstable trinucleotide repeat sequences have been associated with the clinical phenomenon of anticipation (decreasing age of onset in succeeding generations). CTG18.1 is a trinucleotide repeat with the SEF2-1 gene and has been found to be highly unstable when the CTG copy number is greater than 40. The authors studied CTG18.1 in three disorders that have been shown to have evidence of anticipation-bipolar disorder, schizophrenia, and cerebrospinal ataxia. The frequency of the alleles was compared to control populations. The frequency of the unstable alleles was approximately 3% and was similar in all groups, including the controls. There was no association between enlarged CTG18.1 alleles and any of the diseases studied.
Function of the C −36 to T polymorphism in the human cholecystokinin gene promoter T Hansen, JF Rehfeld, FC Nielsen
Recently, a number of studies have indicated that a polymorphism in the cholecystokinin (CCK) gene promoter is associated with alcoholism and withdrawal symptoms as well as panic disorder. The functional significance of the polymorphism on CCK transcription has now been examined by means of binding studies in vitro and activation of the promoter with recombinant Sp1 and Sp3 in vivo. Taken together the results show that the C to T polymorphism does not play a direct role in the pathogenesis of either alcoholism or panic disorder. A putative association to these disorders is likely to be the result of co-segregation with a linked mutation, and future linkage studies may benefit from the application of markers outside the CCK gene.
The first, second, third and fourth order Markov chain analysis on amino acids sequence of human dopamine ␤-hydroxylase G Wu
The human dopamine ␤-hydroxylase (DBH) is the enzyme catalyzing the conversion of dopamine into noradrenaline, and its activity has been found to be altered in schizophrenia. The primary structure of DBH may play a crucial role in its activity. In the primary structure of DBH, the repeated amino acids sequences may be indispensable for its activity, because such repetitions cannot simply be attributed to random chance. In amino acids sequence, the issue of which amino acid is more likely to follow a precedent amino acid can be studied by the Markov transition probability. In this article, the author measured paired, three, four and five amino acids sequences in the human DBH and calculated the Markov transition probability for these sequences. It is suggested that the most frequently appeared amino acids sequences and the amino acids with a high Markov transition probability may serve as the potential targets of new drugs.
